Pilulka Lekarny AS (XPRA:PINK) EV-to-FCF: (As of Jul. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XPRA:PINK Pilulka Lekarny AS XPRA:PINK
52 GF Score
Price Kč110.00
GF Value Kč112.95
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Pilulka Lekarny AS EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Pilulka Lekarny AS's Enterprise Value is Kč333 Mil. Pilulka Lekarny AS's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was Kč0 Mil. Therefore, Pilulka Lekarny AS's EV-to-FCF for today is .

The historical rank and industry rank for Pilulka Lekarny AS's EV-to-FCF or its related term are showing as below:

XPRA:PINK' s EV-to-FCF Range Over the Past 10 Years
Min: -196.62   Med: -14.48   Max: -4.04
Current: -16.32

During the past 6 years, the highest EV-to-FCF of Pilulka Lekarny AS was -4.04. The lowest was -196.62. And the median was -14.48.

XPRA:PINK's EV-to-FCF is ranked worse than
100% of 405 companies
in the Healthcare Providers & Services industry
Industry Median: 18.06 vs XPRA:PINK: -16.32

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2026-07-21), Pilulka Lekarny AS's stock price is Kč110.00. Pilulka Lekarny AS's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was Kč-14.360. Therefore, Pilulka Lekarny AS's PE Ratio (TTM) for today is At Loss.

Pilulka Lekarny AS  (XPRA:PINK) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Pilulka Lekarny AS's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=110.00/-14.360
=At Loss

Pilulka Lekarny AS's share price for today is Kč110.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Pilulka Lekarny AS's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was Kč-14.360.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Pilulka Lekarny AS EV-to-FCF Related Terms

Pilulka Lekarny AS EV-to-FCF Historical Data

* Premium members only.

The historical data trend for Pilulka Lekarny AS's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pilulka Lekarny AS EV-to-FCF Chart

Pilulka Lekarny AS Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EV-to-FCF
Get a 7-Day Free Trial -72.05 -14.81 -10.44 -5.02 -24.27

Pilulka Lekarny AS Semi-Annual Data
Dec20 Dec21 Dec22 Dec23 Jun24 Dec24 Dec25
EV-to-FCF Get a 7-Day Free Trial -14.81 -10.44 0.00 -5.02 -24.27

Pilulka Lekarny AS EV-to-FCF Competitor Comparison

For the Pharmaceutical Retailers subindustry, Pilulka Lekarny AS's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pilulka Lekarny AS EV-to-FCF vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Pilulka Lekarny AS's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Pilulka Lekarny AS's EV-to-FCF falls into.


XPRA:PINK
52GF Score
Pilulka Lekarny AS XPRA:PINK
EV-to-FCF is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pilulka Lekarny AS EV-to-FCF Calculation

Pilulka Lekarny AS's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=333.333/0
=

Pilulka Lekarny AS's current Enterprise Value is Kč333 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Pilulka Lekarny AS's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was Kč0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is Pilulka Lekarny AS (XPRA:PINK) Overvalued in 2026?

Based on GuruFocus' analysis, Pilulka Lekarny AS stock appears to be undervalued. The current stock price of Kč110.00 is trading 2.6% below its estimated GF Value™ of Kč112.95. GuruFocus considers Pilulka Lekarny AS to be Fairly Valued.

Key valuation signals for XPRA:PINK:

  • EV-to-FCF:
  • GF Value™: Kč112.95 vs. price of Kč110.00 (2.6% below fair value)
  • GF Score™: 52/100 with 6 warning signs

No single metric tells the full story. See the XPRA:PINK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pilulka Lekarny AS Business Description

Address Drahobejlova 1073/36, Prague, CZE, 190 00
Pilulka Lekarny AS operates an online pharmaceutical store by distribution of medicinal products. The store offers over-the-counter-drugs, dietary supplements, baby foods, mother care products, cosmetics, other prescription drugs, sport nutritional products, diagnostic test kits, orthopaedic supplies, first aid kits, and other related products.
52GF Score

Get the complete analysis for XPRA:PINK

EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Kč110.00
Price
Kč112.95
GF Value